Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Farxiga approval date?Semaglutide patent expiration dates china india brazil us eu 2026?Semaglutide patent expiration china generics 2024 2025?Atorvastatin calcium discount?Dexamethasone market?
See the DrugPatentWatch profile for vascepa
Vascepa treats high triglycerides (a type of blood fat) in specific adults, and it also helps reduce cardiovascular risk in people with elevated triglycerides who are at higher risk due to existing heart disease or diabetes. [1]
Vascepa is used in people with persistently high triglycerides despite lifestyle changes (diet, exercise) and, when appropriate, statin therapy. Its role goes beyond triglycerides alone because it’s also prescribed to lower the risk of certain cardiovascular events in higher-risk patients. [1]
Vascepa is not used as a general treatment for all causes of triglycerides, and it isn’t described here as a pancreatitis-specific therapy. It’s targeted to the patient groups and triglyceride ranges for which it’s indicated. [1]
The two main goals are lowering triglycerides and reducing the risk of some cardiovascular outcomes in eligible patients. [1] Sources [1] https://www.drugdigest.com/vascepa
Other Questions About Vascepa :